Published in Drug Week, July 18th, 2003
The publication, entitled "BMP-7 counteracts TGF-(beta)1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury," was based on the research of Raghu Kalluri and his associates at the Beth Israel Deaconess Medical Center and the Harvard Medical School.
In the study, which is the first to demonstrate the potential of BMP-7 to promote reversal of the effects of chronic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week